Accession Number: | 0001144204-14-064137 |
Date: | 2014-10-17 |
Issuer: | CORMEDIX INC. (CRMD) |
Original Submission Date: |
TELLEZ CORA M
C/O CORMEDIX INC.
745 ROUTE 202-206, SUITE 303
BRIDGEWATER, NJ US 08807
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.001 PAR VALUE PER SHARE | 2014-10-17 | P | 2,100 | a | $1.55 | 2,300 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.05 | deemed execution date | 0 ( ) | 2024-04-03 | common stock, $0.001 par value per share 30,000 | $2.05 | 30,000 | direct | ||||
SERIES C-3 NON-VOTING CONVERTIBLE PREFERRED SOTCK | 1.0 | deemed execution date | 0 ( ) | common stock, $0.001 par value per share 50,000 | $1.00 | 5,000 | direct | |||||
COMMON STOCK WARRANTS (RIGHT TO BUY) | 0.9 | deemed execution date | 0 ( ) | 2014-01-08 | 2020-01-08 | common stock, $0.001 par value per share 25,000 | $0.90 | 25,000 | direct |
ID | footnote |
---|---|
f1 | the price reported in column 4 is the weighted average price. these shares were purchased in multiple transactions at prices ranging from $1.548 to $1.55. |
f2 | these shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant. |
f3 | on january 8, 2014, the reporting person acquired through a private placement, (i) 5,000 shares of the company's series c-3 non-voting convertible preferred stock, each share convertible into 10 shares of common stock, $0.001 par value per share; and (ii) a five-year warrant to purchase common stock at an exercise price of $1.25 per share. the series c-3 non-voting convertible preferred stock and warrants were purchased together at a purchase price of $10.00 per share. the warrant exercise price was decreased to $0.90 per share effective september 15, 2014. |